These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6463065)

  • 1. A multi-centre, general practice assessment of a timolol/bendrofluazide combination ('Prestim') in the treatment of mild to moderate hypertension.
    Head AC
    Pharmatherapeutica; 1984; 3(10):650-6. PubMed ID: 6463065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timolol/bendrofluazide combination ('Prestim') in the treatment of poorly controlled hypertensive patients in general practice.
    Douglas-Jones AP
    Pharmatherapeutica; 1984; 3(9):631-5. PubMed ID: 6728865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of 500 patients with mild to moderate hypertension who had successfully completed a 3-month general practice study of a timolol-bendrofluazide combination ('Prestim').
    Head AC; Marsh BT; Fairey IT
    Curr Med Res Opin; 1987; 10(8):562-5. PubMed ID: 3315469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-centre general practice study on the use of a timolol/bendrofluazide combination ('Prestim') in the management of hypertension: preliminary report.
    Langrick AF; Head AC
    Curr Med Res Opin; 1981; 7(4):268-75. PubMed ID: 7226875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of timolol/bendrofluazide (Prestim) in the treatment of hypertensive patients failing to respond to other antihypertensives.
    Ellis R; Wood SJ
    J Int Med Res; 1983; 11(6):359-63. PubMed ID: 6140195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prestim in the management of mild to moderate essential hypertension in general practice.
    Peacock K; Hodge B
    J Int Med Res; 1983; 11(3):186-9. PubMed ID: 6347751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A post-marketing acceptability study in 11,685 patients of the efficacy of timolol/bendrofluazide in the management of hypertension in general practice.
    Marsh BT; Atkins MJ; Talbot DJ; Fairey IT
    J Int Med Res; 1987; 15(2):106-14. PubMed ID: 3582721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term usage of Prestim (timolol/bendrofluazide) in the management of mild to moderate hypertension in general practice.
    Hosie J; Jones JC; Clifford PD
    Br J Clin Pract; 1983; 37(11-12):393-6. PubMed ID: 6367796
    [No Abstract]   [Full Text] [Related]  

  • 9. A hospital out-patient study of timolol/bendrofluazide combination ('Prestim') in essential hypertension.
    Kubik MM
    Curr Med Res Opin; 1980; 7(1):47-54. PubMed ID: 7428413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a fixed ratio combination of hydrochlorothiazide, amiloride and timolol ('Moducren') given once versus twice daily in mild to moderate hypertension.
    Young JH; VandenBurg MJ; Isitt VL; Currie WJ
    Pharmatherapeutica; 1984; 4(1):64-8. PubMed ID: 6504947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fixed ratio combination of propranolol and bendrofluazide in the treatment of hypertension.
    Pandhi P; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):92-4. PubMed ID: 3886568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
    Lesk MR; Koulis T; Sampalis F; Sampalis JS; Bastien NR
    Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A general practice study of timolol/hydrochlorothiazide/amiloride ('Moducren'), a new therapy for hypertension, and the doctor's influence on management.
    Parry EE; Arr S; Tait D
    Pharmatherapeutica; 1983; 3(5):294-9. PubMed ID: 6844366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive action of drug combination: Timolol, hydralazine, hydrochlorothiazide and triamterene.
    Pörsti P; Jalonen K; Ryysy L; Toivonen T; Viherkoski M
    Ann Clin Res; 1981 Feb; 13(1):6-10. PubMed ID: 7018363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A crossover comparison of a timolol/bendrofluazide combination and methyldopa in essential hypertension.
    Spira M
    Curr Med Res Opin; 1977; 5(3):252-7. PubMed ID: 162662
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical experience with timolol maleate monotherapy of hypertension.
    Bannon JA; Stewart KA; DeLisser O; Schrogie JJ
    Arch Intern Med; 1986 Apr; 146(4):654-7. PubMed ID: 3963944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components.
    Diestelhorst M; Larsson LI;
    Ophthalmology; 2006 Jan; 113(1):70-6. PubMed ID: 16263174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.
    Barnebey HS; Orengo-Nania S; Flowers BE; Samples J; Mallick S; Landry TA; Bergamini MV
    Am J Ophthalmol; 2005 Jul; 140(1):1-7. PubMed ID: 15990081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timolol and bendrofluazide in the management of hypertension in general practice.
    Wheatley D
    Eur J Clin Pharmacol; 1978 Dec; 14(5):319-24. PubMed ID: 365544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.